Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin and Phentermine Co-administration in Overweight/Obese Subjects
NCT02243202Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of canagliflozin in obesity, sponsored by Janssen Pharmaceutical. Started Sep 2014; status: completed.
02
Drugs
canagliflozin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02243202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02243202.